```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1310 Introduced in House (IH)]

<DOC>

115th CONGRESS
  1st Session
                                H. R. 1310

 To support programs for mosquito-borne and other vector-borne disease 
                       surveillance and control.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 2, 2017

 Mr. Soto (for himself, Mr. Curbelo of Florida, Ms. Castor of Florida, 
Mr. Gaetz, Mr. Crist, Mrs. Demings, Mr. Deutch, Ms. Frankel of Florida, 
   Mr. Hastings, Mr. Lawson of Florida, Mrs. Murphy of Florida, Mr. 
     Perlmutter, Ms. Wasserman Schultz, and Ms. Wilson of Florida) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
 To support programs for mosquito-borne and other vector-borne disease 
                       surveillance and control.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Strengthening Mosquito Abatement for 
Safety and Health Act'' or the ``SMASH Act''.

SEC. 2. REAUTHORIZATION OF MOSQUITO ABATEMENT FOR SAFETY AND HEALTH 
              PROGRAM.

    Section 317S of the Public Health Service Act (42 U.S.C. 247b-21) 
is amended--
            (1) in subsection (a)(1)(B)--
                    (A) by inserting ``including programs to address 
                emerging infectious mosquito-borne diseases,'' after 
                ``control programs,''; and
                    (B) by inserting ``or improving existing control 
                programs'' before the period at the end;
            (2) in subsection (b)--
                    (A) in paragraph (1), by inserting ``, including 
                improvement,'' after ``operation'';
                    (B) in paragraph (2)--
                            (i) in subparagraph (A)--
                                    (I) in clause (ii), by striking 
                                ``or'' at the end;
                                    (II) in clause (iii), by striking 
                                the semicolon at the end and inserting 
                                ``, including an emerging infectious 
                                mosquito-borne disease that presents a 
                                serious public health threat; or''; and
                                    (III) by adding at the end the 
                                following:
                            ``(iv) a public health emergency due to the 
                        incidence or prevalence of a mosquito-borne 
                        disease that presents a serious public health 
                        threat.''; and
                            (ii) in subparagraph (D), by inserting ``or 
                        that demonstrates to the Secretary that the 
                        control program is consistent with existing 
                        State mosquito control plans, or policies, or 
                        other applicable State preparedness plans'' 
                        before the period at the end;
                    (C) in paragraph (4)(C), by striking ``that 
                extraordinary'' and all that follows through the period 
                at the end and inserting ``that--
                            ``(i) extraordinary economic conditions in 
                        the political subdivision or consortium of 
                        political subdivisions involved justify the 
                        waiver; or
                            ``(ii) the geographical area covered by a 
                        political subdivision or consortium for a grant 
                        under paragraph (1) has an extreme need due 
                        to--
                                    ``(I) the size or density of the 
                                human population;
                                    ``(II) the size or density of the 
                                mosquito population; or
                                    ``(III) the severity of the 
                                mosquito-borne disease, such that 
                                expected serious adverse health 
                                outcomes for the human population 
                                justify the waiver.''; and
                    (D) by amending paragraph (6) to read as follows:
            ``(6) Number of grants.--A political subdivision or a 
        consortium of political subdivisions may not receive more than 
        one grant under paragraph (1).''; and
            (3) in subsection (f)--
                    (A) in paragraph (1), by striking ``$100,000,000 
                for fiscal year 2003, and such sums as may be necessary 
                for each of fiscal years 2004 through 2007'' and 
                inserting ``$130,000,000 for each of fiscal years 2018 
                through 2023'';
                    (B) in paragraph (2), by striking ``the Public 
                Health Security and Bioterrorism Preparedness and 
                Response Act of 2002'' and inserting ``other medical 
                and public health preparedness and response laws''; and
                    (C) in paragraph (3)--
                            (i) in the heading, by striking ``2004'' 
                        and inserting ``2018''; and
                            (ii) by striking ``2004'' and inserting 
                        ``2018''.

SEC. 3. EPIDEMIOLOGY-LABORATORY CAPACITY GRANTS.

    Section 2821 of the Public Health Service Act (42 U.S.C. 300hh-31) 
is amended--
            (1) in subsection (a)(1), by inserting ``, including 
        mosquito and other vector-borne diseases,'' after ``infectious 
        diseases''; and
            (2) in subsection (b), by striking ``2010 through 2013'' 
        and inserting ``2018 through 2023''.

SEC. 4. GAO STUDY.

    (a) Study.--The Comptroller General of the United States shall 
conduct a study on the state of surveillance and control of mosquito-
borne infectious diseases in the United States and territories, 
including the state of preparedness for conducting such surveillance 
and control. The study shall include--
            (1) a description of the infrastructure and programs for 
        mosquito control in the United States, including--
                    (A) how such infrastructure and programs are 
                organized and implemented at the Federal, State, and 
                local levels, including with respect to departments and 
                agencies of the States, and local organizations 
                (including special districts) involved in such control 
                programs;
                    (B) the role of the private sector in such 
                activities;
                    (C) how the authority for mosquito control impacts 
                such activities; and
                    (D) the resources for such infrastructure and 
                programs, including Federal, State, and local funding 
                sources;
            (2) how mosquito and other vector-borne disease 
        surveillance and control is integrated into Federal, State, and 
        local preparedness plans and actions, including how zoonotic 
        surveillance is integrated into infectious disease surveillance 
        to support real-time situational surveillance and awareness;
            (3) Federal, State, and local laboratory capacity for 
        emerging vector-borne diseases, including mosquito-borne and 
        other zoonotic diseases; and
            (4) any regulatory challenges for developing and utilizing 
        vector-control technologies and platforms as part of mosquito 
        control strategies.
    (b) Consultations.--In conducting the study under subsection (a), 
the Comptroller General of the United States shall consult with--
            (1) State and local public health officials involved in 
        mosquito and other vector-borne disease surveillance and 
        control efforts;
            (2) researchers and manufacturers of mosquito control 
        products;
            (3) stakeholders involved in mosquito abatement activities;
            (4) infectious disease experts; and
            (5) entomologists involved in mosquito-borne disease 
        surveillance and control efforts.
    (c) Report.--Not later than 18 months after the date of enactment 
of this Act, the Comptroller General of the United States shall submit 
to the Committee on Health, Education, Labor, and Pensions of the 
Senate and the Committee on Energy and Commerce of the House of 
Representatives a report containing the results of the study conducted 
under subsection (a) and relevant recommendations for Zika virus and 
other mosquito-borne diseases preparedness and response efforts.
                                 <all>
```